[1]
M. Haj Manochehri, F. Azizi, M. Rahimi, and M. D. Omrani, “Association of rs16917496 polymorphism at the miR-502 binding site in the SET8 3’UTR with the risk of Prostate Cancer and benign prostatic hyperplasia”, Novel Biomed, vol. 6, no. 2, pp. 74-78, Apr. 2018.